ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,005.20
      -0.91%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      81.875
      0.00%
      Bitcoin
      66,493.18
      -0.34%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Longboard Pharmaceuticals Inc (LBPH)

      7. Longboard Pharmaceuticals Inc (LBPH) Financials

      Longboard Pharmaceuticals Inc

      Longboard Pharmaceuticals Inc (LBPH)

      NASDAQ
      35.95
      -0.05
      (-0.14%)
      Closed July 19 4:00PM
      Delayed by 15 minutes
      35.95
      0.07
      (0.20%)
      After Hours: 5:30PM
      Delayed by 15 minutes

      Longboard Pharmaceuticals Inc Financial Summary

      The current LBPH market cap is 1.4B. The company's latest EPS is USD -1.3997 and P/E is -25.63.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -11.96M-15.64M-13.58M-15.57M-18.11M
      Net Income -11.46M-15M-12.93M-15.03M-14.99M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0000
      Operating Income -14.4M-27.84M-44.8M-56.76M
      Net Income -14.4M-27.8M-43.95M-54.42M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 79.68M66.22M58.86M50.7M327.67M
      Total Liabilities 7.55M8.12M6.82M9.77M13.96M
      Total Equity 72.13M58.11M52.04M40.92M313.71M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 56.24M108.95M70.62M50.7M
      Total Liabilities 3.14M5.63M9.15M9.77M
      Total Equity -2.69M103.32M61.47M40.92M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Operating -13.1M-26.55M-39.84M-50.87M-15.18M
      Investing 6.08M14.05M25.79M24.23M-230.92M
      Financing 21.36M21.24M27.18M30.19M286.4M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Operating -3.44M-24.71M-38.06M-50.87M
      Investing N/A -40.72M-17.06M24.23M
      Financing 58.76M76.45M-444k30.19M

      Stats and Ratios

      Market Cap 1.4B
      Price to Earnings Ratio -25.63
      Price to Sales Ratio 0
      Price to Cash Ratio 97.34
      Price to Book Ratio 34.09
      Dividend Yield -

      Share Statistics

      Shares Outstanding 38.88M
      Average Volume (1 week) 715.12k
      Average Volume (1 Month) 958.98k
      52 Week Change 399.31%
      52 Week High 40.48
      52 Week Low 3.60
      Spread (Intraday) 8.59 (21.69%)

      Company Info

      Company Name Longboard Pharmaceuticals Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.longboardpharma.com
      Industry pharmaceutical preparations (2834)